General discussion, page-176

Ill answer you in good faith.

In case you forgot, the Cannvalate options were given as a deal so that Cannvalate would pay the majority of the fees of the trials, IHL contribution being capped at 80K per trial. Each trial would be costing millions to run, which we dont have the $$$.

We are giving Cannvalate this equity and simultaneously adding to our own balance sheet, far more worth it than trying to capital raise the money for the trials.

Yes the 2 and 3c options were generous but they go up to 14c in increasing numbers. Now Cannvalate has skin in the game with us. Also I never said to reward missed deadlines, the oppies only vest on milestone completion. Thus far those have not failed to happen.